Sunbed campaigner acknowledged as one of most influential Australians
17 December 2014
Congratulations to MIA’s Community Co-ordinator, Jay Allen, for being acknowledged on the honour roll of Australia’s most influential people in the non-profit sector.
As a former sunbed user, Jay was diagnosed with stage 3 melanoma in 2008 – a diagnosis that changed his life, turning the former truck driver into a passionate advocate to have sunbeds banned across Australia.
“I started the campaign to ban solariums in Australia in December 2008 because I wasn’t aware of the risks involved when I used them. I didn’t want others to go through what I did by exposing themselves to the harm of these dangerous machines, not knowing the risks associated with them.” Jay says. “With this ban, our future generations will reap the benefits.”
By teaming up with Greens Senator Lee Rhiannon, NSW Greens MP Dr John Kaye, and leading health professor at The University of Sydney Professor Simon Chapman, and together with the support of Melanoma Institute Australia, Jay has ensured the banning of solariums got the attention it deserved.
“I’ve had many meetings with politicians all over Australia sharing my messages about the dangers of solarium use, ran petitions, awareness days, etc.” says Jay. “Persistence has been the key and always speaking from the heart about a real issue that is costing many Australians their life.”
Jay started the campaign that saw sunbeds banned initially in NSW and then throughout Australia. He continues to passionately raise awareness of melanoma and funds for a cure. His campaigning has now moved to New Zealand where he has teamed up with melanoma survivors and key organisations to achieve a ban.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.
Australian researchers pioneer life-extending treatment for advanced melanoma patients with brain tumours
Australian researchers are the first to demonstrate that patients with advanced melanoma which has spread to the brain can have increased life expectancy and possibly even beat the disease.
Melanoma March 2017 - that's a wrap! Thank you to everyone that helped make it happen.
Thank you so much to all those who contributed in a variety of ways to Melanoma March 2017 in 17 different locations and more around the country! You have contributed to getting the Big Data for Melanoma national Research Project happening!
By looking at the ‘dark matter’ of the genome, new research has found that genetic changes in acral and mucosal melanoma are completely different to mutations found in skin melanoma.
‘Slip, slop, slap’ is synonymous with being Australian and playing it safe in the sun. These sun smart rules reduce our chances of getting melanoma of the skin. However, new research tells a different story for those affected by rarer forms of melanoma.
Using MIA's patient database, researchers have developed conditional survival estimates for Stage III melanoma patients to more accurately predict survival outcomes.
MIA is proud to be celebrating an important milestone – the 60th anniversary of melanoma research and Australian-led global efforts to find a cure.
Research achievements by MIA were celebrated at the annual Sydney Medical School recently.
In this Global Research Report we showcase advances in medical oncology, reveal unexpected pathology in acral and skin melanoma, and uncover biomarkers and new gene targets for melanoma.
Professor’s Long and Scolyer are well known in the academic community and beloved by their patients. But we wanted to get to know our new Conjoint Medical Directors a little more and hear their plans on making an impact on melanoma.
Wyong Rugby League Club Group has joined forces with Melanoma Institute Australia to help end melanoma for future generations.
Melanoma research has reached a milestone with the 10,000th patient giving their permission for their blood and tissue samples to be used in the world’s largest melanoma biospecimen bank.
MIA's researchers and clinicians are in Seattle, USA, today sharing their research findings at the prestigious Society of Surgical Oncology’s Annual Cancer Symposium.
Two of the world’s best minds in melanoma have taken over the academic and clinical leadership of Melanoma Institute Australia (MIA). Professor Georgina Long and Professor Richard Scolyer are the new Conjoint Medical Directors of MIA, and are shaping the future direction of melanoma research, treatment and education.
Meet Georgia, our Clinica Nurse Consultant who provides vital care and education for patients throughout their treatment.
Australia, we need to talk. This week’s dramatic episodes of Married At First Sight have highlighted a tragedy which is ripping Australian families apart. Yet no one is talking about it.
To celebrate International Women's Day 2017, MIA shares how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.
We welcome Mr Grant King to the position of Chairman of the Board of Melanoma Institute Australia, following the retirement of Mr Reg Richardson AM who led the organisation for 10 years.